Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Oxford Vaccine Group are inviting students in school year 12 to take part in a research project to understand whether immunising teenagers with vaccines against ‘Meningitis B’ could protect them and the rest of the community against these potentially deadly bacteria. This is a national study involving 24 000 year 12 students across the United Kingdom. Teenagers at participating schools are being asked to take part by local research teams involved.

Meningitis is caused by an infection around the surface of the brain. It is rare but can be life-threatening and mostly affects babies, young children and adolescents. An important cause of meningitis is a type of bacteria (or germs) called meningococcus.

For more information, please visit  http://beontheteam.uk/ or http://trials.ovg.ox.ac.uk/trials/be-on-the-team

What is the ‘Be on the TEAM’ study?

  • This study will see if immunising teenagers with MenB vaccines reduces the carriage of meningococcus in teenager’s throats, which could in turn protect the broader community
  • Teenagers who take part will receive 2 doses of a Meningitis B vaccine
  • These are licensed vaccines that teenagers would not otherwise receive, and will reduce their risk of meningitis
  • Participants would have two throat swabs taken 1 year apart
  • There would be three study visits, over 12 to 18 months
  • All visits would be held within participating schools

Which schools are taking part?

The schools listed below are participating within the Thames Valley

    • Cheney School, Oxford
    • The Grange School, Aylesbury
    • Kennet School, Thatcham
    • King Alfred’s Academy, Wantage
    • Matthew Arnold School, Oxford
    • Our Lady’s School, Abingdon
    • Queen Anne’s School, Caversham
    • Tudor Hall School, Banbury
    • Park House School, Newbury
    • Radley College, Abingdon
    • Magdalen College School, Oxford
    • St Bartholomew's School, Newbury
    • Oxford High School, Oxford
    • Headington School, Oxford

    Where can I find out more information?

    The Oxford Vaccine Group study information booklets contain more information (Information booklet)

    If you would like any further information regarding the study please contact the study team on:

    Email: mencarriage@ovg.ox.ac.uk

    Tel: 01865611400

    Many thanks,

    The MenB Carriage Team

    Oxford Vaccine Group

     

    Similar stories

    COVID-19 vaccine messaging that focuses on personal benefits is most effective with those who are hesitant

    For the one in ten who say they won’t take a COVID-19 vaccine, messaging that focuses on personal rather than collective benefits is more effective.

    How do nucleic acid vaccines work?

    Ever wondered what happens inside your cells when you are infected with a virus? Or wondered how the new COVID-19 vaccines work? The answer to both of these questions can be found in how our cells receive instructions to make proteins. Actually, our cells are a bit like factories...

    Increasing vaccine uptake among ethnic minorities

    Dr Samantha Vanderslott and Dr Seilesh Kadambari discuss their collaborative approach to providing ethnic minority groups with information on vaccines.

    COVID-19: how to tackle vaccine hesitancy among BAME groups

    Samantha Vanderslott, Andrew Pollard and Seilesh Kadambari discuss vaccine uptake among Black, Asian and minority ethnic communities in an article for The Conversation.

    Oxford University extends COVID-19 vaccine study to children

    The University of Oxford, together with three partner sites in London, Southampton and Bristol, is to launch the first study to assess the safety and immune responses in children and young adults of the ChAdOx1 nCoV-19 coronavirus vaccine.

    World Health Organization experts provide guidance on use of the Oxford vaccine

    WHO SAGE says Oxford's coronavirus vaccine is safe and likely to be efficacious in older adults, and recommends its use in this age group.